Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.
3 people · 0 jobs
2 people · 0 jobs
3 people · 0 jobs
2 people · 0 jobs
4 people · 0 jobs
0 people · 0 jobs